- (3) Worse Than the Disease? Reviewing Some Possible Unintended Consequences of the mRNA Vaccines Against COVID-19
- (10) Multiple Vaccinations and the Enigma of Vaccine Injury
- (11) mRNA vaccines — a new era in vaccinology
- (77) Imperfect Vaccination Can Enhance the Transmission of Highly Virulent Pathogens
- (12) Antibody-dependent enhancement and SARS-CoV-2 vaccines and therapies
- (13) Evidence for increased breakthrough rates of SARS-CoV-2 variants of concern in BNT162b2 mRNA vaccinated individuals
- (14) The plasmablast response to SARS-CoV-2 mRNA vaccination is dominated by non-neutralizing antibodies and targets both the NTD and the RBD
- (15) Nearly 40% of new COVID patients were vaccinated – compared to just 1% who had been infected previously
- (16) Diagram över infektioner i Vermont i Juli 2021
- (18) Covid-19 and dengue: Double punches for dengue-endemic countries in Asia
- (19) Potential antigenic cross-reactivity between SARS-CoV-2 and Dengue viruses
- (20) Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus
- (1) Reaction of Human Monoclonal Antibodies to SARS-CoV-2 Proteins With Tissue Antigens: Implications for Autoimmune Diseases
- (22) Persistent Antiphospholipid Antibodies, Mast Cell Activation Syndrome, Postural Orthostatic Tachycardia Syndrome and Post-COVID Syndrome: 1 Year On
- (23) Prothrombotic autoantibodies in serum from patients hospitalized with COVID-19
- (24) Clinically identifiable autoreactivity is common in severe SARS-CoV-2 Infection
- (25) Clinically significant anticardiolipin antibodies associated with COVID-19
- (26) IgM autoantibodies recognizing ACE2 are associated with severe COVID-19
- (27) Immunization with SARS coronavirus vaccines leads to pulmonary immunopathology on challenge with the SARS virus
- (67) Regulation of NF-κB in Autoimmunity
- (17) Angiotensin receptors: a new role in cancer?
- (58) Interleukin 6
- (89) ACE2, Much More Than Just a Receptor for SARS-COV-2
- (90) GRP78: a chaperone with diverse roles beyond the endoplasmic reticulum
- (91) Prion disease is accelerated in mice lacking stress-induced heat shock protein 70 (HSP70)
- (92) The Enigma of Heat Shock Proteins in Immune Tolerance
- (93) Understanding SARS-CoV-2-Mediated Inflammatory Responses: From Mechanisms to Potential Therapeutic Tools
- (94) Molecular Mechanism for Antibody-Dependent Enhancement of Coronavirus Entry
- (64) Pfizer Data Show: Where do the lipid nanoparticles collect
- (65) 厚生省に提出されたファイザーワクチン極秘データ
- Mängd S1 och S-proteiner i blodet efter giftinjektionerna.
- (152) Persistence of SARS CoV-2 S1 Protein in CD16+ Monocytes in Post-Acute Sequelae of COVID-19 (PASC) Up to 15 Months Post-Infection
- (203) The Pfizer mRNA vaccine: pharmacokinetics and toxicity
- (29) “A Medically Induced Disease Being Produced By This [giftinjektion]” – [15/7/21]
- (98) Thrombosis With Thrombocytopenia After the Messenger RNA–1273 Vaccine
- (99) SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia
- (100) SARS-CoV-2 spike protein S1 induces fibrin(ogen) resistant to fibrinolysis: Implications for microclot formation in COVID-19
- (119) COVID-19 can affect the blood. Its spike protein may be the culprit
- (131) Antibody epitopes in vaccine-induced immune thrombotic thrombocytopaenia
- (146) SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19
- (187) SARS-CoV-2 spike protein induces abnormal inflammatory blood clots neutralized by fibrin immunotherapy
- (9) SARS-CoV-2 Spike Protein Impairs Endothelial Function via Downregulation of ACE 2
- (30) Cardiolipin, the Mitochondrial Signature Lipid: Implication in Cancer
- (101) S2 subunit of SARS-nCoV-2 interacts with tumor suppressor protein p53 and BRCA: an in silico study
- (151) New-Onset Neurologic Symptoms and Related Neuro-Oncologic Lesions Discovered After COVID-19 Vaccination: Two Neurosurgical Cases and Review of Post-Vaccine Inflammatory Reponses
- (156) SARS-CoV-2 spike protein dictates syncytium-mediated lymphocyte elimination
- (157) Syncytia formation by SARS-CoV-2-infected cells
- (73) Covid-19 vaccines: In the rush for regulatory approval, do we need more data?
- (133) Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine
- (134) This is Nuts, Moderna and Pfizer Intentionally Lost The Clinical Trial Control Group Testing Vaccine Efficacy and Safety
- (198) Systems vaccinology of the BNT162b2 mRNA vaccine in humans
- (206) Covid-19: Researcher blows the whistle on data integrity issues in Pfizer’s vaccine trial
- (31) Israel Spots Probable Link Between Pfizer Vaccine, Myocarditis
- (32) Doctor: Heart Failure from mRNA Jabs “Will Kill Most People”
- (33) Myocarditis and Pericarditis After Vaccination for COVID-19
- (34) Risk of acute myocardial infarction and ischaemic stroke following COVID-19 in Sweden: a self-controlled case series and matched cohort study
- (103) Association of Myocarditis With BNT162b2 Messenger RNA COVID-19 Vaccine in a Case Series of Children
- (143) Anti–SARS–CoV–2 Immune Response and Sudden Death: Titin as a Link
- (172) Selectively expressing SARS-CoV-2 Spike protein S1 subunit in cardiomyocytes induces cardiac hypertrophy in mice
- (176) Intravenous Injection of Coronavirus Disease 2019 (COVID-19) mRNA Vaccine Can Induce Acute Myopericarditis in Mouse Model
- (142) COVID-19 Vaccine-Induced Radiation Recall Phenomenon
- (162) Toxic Epidermal Necrolysis Post COVID-19 Vaccination – First Reported Case
- (178) Association of Facial Pustular Neutrophilic Eruption With Messenger RNA-1273 SARS-CoV-2 Vaccine
- (179) Delayed Localized Hypersensitivity Reactions to the Moderna COVID-19 Vaccine
- (180) Incidence of Cutaneous Reactions After Messenger RNA COVID-19 Vaccines
- (186) Development of severe pemphigus vulgaris following ChAdOx1 nCoV-19 vaccination and review of literature
- (205) Morbilliform rash after administration of Pfizer-BioNTech COVID-19 mRNA vaccine
- (4) Engineered protein crystals make cells magnetic
- (5) Magnetically controlled, hydrogel-based smart transformers
- (6) Recent Advances on Magnetic Sensitive Hydrogels in Tissue Engineering
- (7) Superparamagnetic nanoparticle delivery of DNA vaccine
- (8) SARS-CoV-2 Spike protein RBD-coupled magnetic beads
- (48) Graphene Oxide Conjugated Magnetic Beads for RNA Extraction
- (49) Atomic-scale control of graphene magnetism by using hydrogen atoms
- (71) DEADLY SHOTS! Former Pfizer Employee Confirms Poison in COVID ‘Vaccine’
- (2) First manifestation of multiple sclerosis after immunization with the Pfizer-BioNTech COVID-19 vaccine.
- (38) COVID-19 RNA Based Vaccines and the Risk of Prion Disease
- (39) SARS-COV-2 VACCINES AND NEURODEGENERATIVE DISEASE
- (40) SARS-CoV-2 spike protein interactions with amyloidogenic proteins: Potential clues to neurodegeneration
- (41) FDA To Add Warning Over Rare Neurological Side Effects Linked To J&J Jabs
- (42) Annexin A2 Deficiency Exacerbates Neuroinflammation and Long-Term Neurological Deficits after Traumatic Brain Injury in Mice
- (43) COVID-19 Vaccine Associated Parkinson’s Disease, A Prion Disease Signal in the UK Yellow Card Adverse Event Database
- (44) Endothelial cell damage is the central part of COVID-19 and a mouse model induced by injection of the S1 subunit of the spike protein?
- (111) A phase 1/2/3, placebo-controlled, randomized, observer-blind, dose-finding study to evaluate the safety, tolerability, immunogenicity, and efficacy of SARS-CoV-2 RNA vaccine candidates against Covid-19 in healthy individuals
- (112) Molecular and Microscopic Analysis of Bacteria and Viruses in Exhaled Breath Collected Using a Simple Impaction and Condensing Method
- (137) Proteomic characterization of human exhaled breath condensate
- (138) Exhaled breath condensate [EBC] as a potential specimen for diagnosing COVID-19
- (52) Molecular mimicry between SARS-CoV-2 spike glycoprotein and mammalian proteomes: implications for the vaccine
- (54) New peer reviewed study on COVID-19 vaccines suggests why heart inflammation, blood clots and other dangerous side effects occur
- (55) Lipid bilayer degradation induced by SARS-CoV-2 spike protein as revealed by neutron reflectometry
- (56) SARS-CoV-2 Infects the Brain Choroid Plexus and Disrupts the Blood-CSF Barrier in Human Brain Organoids
- (57) SARS-CoV-2 spike protein promotes IL-6 trans-signaling by activation of angiotensin II receptor signaling in epithelial cells
- (62) SARS-CoV-2 spike protein binds to bacterial lipopolysaccharide and boosts proinflammatory activity
- (113) SARS-CoV-2 Entry Receptor ACE2 Is Expressed on Very Small CD45- Precursors of Hematopoietic and Endothelial Cells and in Response to Virus Spike Protein Activates the Nlrp3 Inflammasome
- (159) SARS-CoV-2 spike promotes inflammation and apoptosis through autophagy by ROS-suppressed PI3K/AKT/mTOR signaling
- (59) Annexin A2 on lung epithelial cell surface is recognized by severe acute respiratory syndrome-associated coronavirus spike domain 2 antibodies
- (60) Antibodies directed against annexin A2 and obstetric morbidity
- (61) Pathophysiology of the antiphospholipid antibody syndrome
- (66) Autoimmunity to Annexin A2 predicts mortality among hospitalised COVID-19 patients
- (63) Patent No.: US 10,702,600 B1
- (68) Antikroppar efter mild covid-19 håller i minst ett år och binder också den nya Delta-varianten
- (69) Vaccine Safety FAQ
- (70) Reactive arthritis after COVID-19 vaccination
- (75) Trump’s doctor Vladimir Zelenko talks to Israeli politicians and health minister about vaccine
- (76) Toxicological insights of Spike fragments SARS-CoV-2 by exposure environment: A threat to aquatic health?
- (116) Open Letter to Dr. Bonnie Henry from BC Physician re: Moderna Vaccine Reactions
- (117) Top American doctor: COVID shots are ‘obsolete,’ dangerous, must be shut down